FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306673418> ?p ?o ?g. }

• W4306673418 endingPage "2209" @default.
• W4306673418 startingPage "2209" @default.
• W4306673418 abstract "The natural limitations of regeneration in the CNS are major problems for the treatment of neurological disorders, including ischaemic brain strokes. Among the approaches being actively developed to inhibit post-ischaemic negative consequences is the delivery of therapeutic genes encoding neuroprotective molecules to the brain. Unfortunately, there are currently no proven and available medicines that contain recombinant human genes for the treatment of ischaemic cerebral stroke. Of particular interest is the development of treatments for patients at risk of ischaemic stroke. In the present study, we propose a proof of concept for the use of an autologous, genetically enriched leucoconcentrate temporally secreting recombinant vascular endothelial growth factor (VEGF), glial-cell-line-derived neurotrophic factor (GDNF) and the neural cell adhesion molecule (NCAM) for the treatment of stroke. In a mini-pig ischaemic stroke model, genetically enriched leucoconcentrate was infused 4 h after surgery (gene therapy in acute phase) or 2 days before stroke modelling (preventive gene therapy). On day 21, after the stroke modelling, the post-ischaemic brain recovery was examined by morphologic and immunofluorescence analysis. The benefits of treating a stroke with genetically enriched leucoconcentrate both for preventive purposes and in the acute phase were confirmed by an improved performance in behavioural tests, higher preservation of brain tissue and positive post-ischaemic brain remodelling in the peri-infarct area. These results suggest that the employment of autologous leucocytes enabling the temporary production of the recombinant therapeutic molecules to correct the pathological process in the CNS may be one of the breakthrough approaches in gene therapy." @default.
• W4306673418 created "2022-10-19" @default.
• W4306673418 creator A5001013377 @default.
• W4306673418 creator A5005313486 @default.
• W4306673418 creator A5008928332 @default.
• W4306673418 creator A5012479293 @default.
• W4306673418 creator A5013445502 @default.
• W4306673418 creator A5042885259 @default.
• W4306673418 creator A5045575672 @default.
• W4306673418 creator A5052784113 @default.
• W4306673418 creator A5056399933 @default.
• W4306673418 creator A5079139828 @default.
• W4306673418 date "2022-10-17" @default.
• W4306673418 modified "2023-09-30" @default.
• W4306673418 title "Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model" @default.
• W4306673418 cites W1534539362 @default.
• W4306673418 cites W1564522823 @default.
• W4306673418 cites W1604336286 @default.
• W4306673418 cites W1903017783 @default.
• W4306673418 cites W1966869460 @default.
• W4306673418 cites W1973838857 @default.
• W4306673418 cites W1976764225 @default.
• W4306673418 cites W1977906437 @default.
• W4306673418 cites W1986555011 @default.
• W4306673418 cites W1998419839 @default.
• W4306673418 cites W2001619373 @default.
• W4306673418 cites W2003453883 @default.
• W4306673418 cites W2008303238 @default.
• W4306673418 cites W2043433978 @default.
• W4306673418 cites W2064704194 @default.
• W4306673418 cites W2074682842 @default.
• W4306673418 cites W2080661641 @default.
• W4306673418 cites W2092384268 @default.
• W4306673418 cites W2321247721 @default.
• W4306673418 cites W2327256548 @default.
• W4306673418 cites W2405223223 @default.
• W4306673418 cites W2537514301 @default.
• W4306673418 cites W2742992776 @default.
• W4306673418 cites W2790979192 @default.
• W4306673418 cites W3080563732 @default.
• W4306673418 cites W3084004666 @default.
• W4306673418 cites W3087735075 @default.
• W4306673418 cites W3093285665 @default.
• W4306673418 cites W3183471743 @default.
• W4306673418 cites W4206826556 @default.
• W4306673418 cites W4211070880 @default.
• W4306673418 cites W4252992061 @default.
• W4306673418 doi "https://doi.org/10.3390/pharmaceutics14102209" @default.
• W4306673418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36297644" @default.
• W4306673418 hasPublicationYear "2022" @default.
• W4306673418 type Work @default.
• W4306673418 citedByCount "1" @default.
• W4306673418 countsByYear W43066734182023 @default.
• W4306673418 crossrefType "journal-article" @default.
• W4306673418 hasAuthorship W4306673418A5001013377 @default.
• W4306673418 hasAuthorship W4306673418A5005313486 @default.
• W4306673418 hasAuthorship W4306673418A5008928332 @default.
• W4306673418 hasAuthorship W4306673418A5012479293 @default.
• W4306673418 hasAuthorship W4306673418A5013445502 @default.
• W4306673418 hasAuthorship W4306673418A5042885259 @default.
• W4306673418 hasAuthorship W4306673418A5045575672 @default.
• W4306673418 hasAuthorship W4306673418A5052784113 @default.
• W4306673418 hasAuthorship W4306673418A5056399933 @default.
• W4306673418 hasAuthorship W4306673418A5079139828 @default.
• W4306673418 hasBestOaLocation W43066734181 @default.
• W4306673418 hasConcept C104317684 @default.
• W4306673418 hasConcept C111599444 @default.
• W4306673418 hasConcept C126322002 @default.
• W4306673418 hasConcept C127413603 @default.
• W4306673418 hasConcept C142724271 @default.
• W4306673418 hasConcept C160539049 @default.
• W4306673418 hasConcept C170493617 @default.
• W4306673418 hasConcept C185856081 @default.
• W4306673418 hasConcept C25498285 @default.
• W4306673418 hasConcept C2780645631 @default.
• W4306673418 hasConcept C51456166 @default.
• W4306673418 hasConcept C55493867 @default.
• W4306673418 hasConcept C71924100 @default.
• W4306673418 hasConcept C78519656 @default.
• W4306673418 hasConcept C86803240 @default.
• W4306673418 hasConcept C92020748 @default.
• W4306673418 hasConceptScore W4306673418C104317684 @default.
• W4306673418 hasConceptScore W4306673418C111599444 @default.
• W4306673418 hasConceptScore W4306673418C126322002 @default.
• W4306673418 hasConceptScore W4306673418C127413603 @default.
• W4306673418 hasConceptScore W4306673418C142724271 @default.
• W4306673418 hasConceptScore W4306673418C160539049 @default.
• W4306673418 hasConceptScore W4306673418C170493617 @default.
• W4306673418 hasConceptScore W4306673418C185856081 @default.
• W4306673418 hasConceptScore W4306673418C25498285 @default.
• W4306673418 hasConceptScore W4306673418C2780645631 @default.
• W4306673418 hasConceptScore W4306673418C51456166 @default.
• W4306673418 hasConceptScore W4306673418C55493867 @default.
• W4306673418 hasConceptScore W4306673418C71924100 @default.
• W4306673418 hasConceptScore W4306673418C78519656 @default.
• W4306673418 hasConceptScore W4306673418C86803240 @default.
• W4306673418 hasConceptScore W4306673418C92020748 @default.
• W4306673418 hasFunder F4320324099 @default.

• next